Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/27/2001 | US20010056075 Chimeric polypeptides of serum albumin and uses related thereto |
12/27/2001 | US20010056074 Novel lipophilic compounds having affinity with nucleic acids and therapeutical uses thereof |
12/27/2001 | US20010055795 Polyhydroxyalkanoate synthase and gene encoding the same enzyme |
12/27/2001 | US20010055793 Generating preferential sugars; incubate sugar with enzyme, recover preferential sugar |
12/27/2001 | US20010055791 Methods for enhancing the production of interferon in cell culture |
12/27/2001 | US20010055790 Genetically engineered proteins for use in the treatment of cancer, cardiovascular, neurological and developmental disorders |
12/27/2001 | US20010055789 Nucleotide sequences for use in the generation of amidated peptides |
12/27/2001 | US20010055788 Recombinant bacterial phytases and uses thereof |
12/27/2001 | US20010055782 Enzymatic protein for use in the diagnosis, treatment and prevention of alzheimer's disease and nervous system disorders |
12/27/2001 | US20010055768 Multilayer; transparent support, thin metal film and intercalation compound containing nucleic acids |
12/27/2001 | US20010055767 Nucleotide sequences coding preferential polypeptides; for use as a diagnostic tool cellular analysis |
12/27/2001 | US20010055759 Serotype-specific probes for listeria monocytogenes |
12/27/2001 | US20010055758 Reagents and methods useful for detecting diseases of the prostate |
12/27/2001 | US20010055756 Internal de novo initiation sites of the HCV NS5B polymerase and use thereof |
12/27/2001 | US20010055755 Dendritic marker-expressing macrophage cultures and methods for reactivating latent HCMV |
12/27/2001 | US20010055596 Compositions and methods for therapy and diagnosis of colon cancer |
12/27/2001 | US20010055590 Method for enhancing myoblast migration and invasion in the context of gene therapy |
12/27/2001 | US20010055586 Methods and means for targeted gene delivery |
12/27/2001 | US20010055584 Improved nucleic acids encoding a chimeric glycosyltransferase |
12/27/2001 | CA2805216A1 Antigenic polypeptides from staphylococcus |
12/27/2001 | CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
12/27/2001 | CA2414065A1 Cgi-69 compositions and methods of use |
12/27/2001 | CA2414062A1 Frozen tissue microarrays and methods for using the same |
12/27/2001 | CA2414046A1 Conserved diaphanous-related formin autoregulatory domain (dad) |
12/27/2001 | CA2414033A1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
12/27/2001 | CA2414028A1 Low oxygen affinity mutant hemoglobins |
12/27/2001 | CA2414020A1 Methods and compositions for the treatment of peripheral artery disease |
12/27/2001 | CA2414015A1 Human receptors |
12/27/2001 | CA2414010A1 Secreted redox proteins |
12/27/2001 | CA2414005A1 Novel compounds |
12/27/2001 | CA2413986A1 Gp354 nucleic acids and polypeptides |
12/27/2001 | CA2413974A1 Neuroactive peptides for treatment of hypoxia and related conditions |
12/27/2001 | CA2413959A1 Fusion proteins of mycobacterium tuberculosis |
12/27/2001 | CA2413870A1 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same |
12/27/2001 | CA2413801A1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
12/27/2001 | CA2413754A1 Canine hepatocyte growth factor |
12/27/2001 | CA2413612A1 Modified construct downstream of the initiation codon for recombinant protein overexpression |
12/27/2001 | CA2413556A1 Positively-charged peptide nucleic acid analogs with improved properties |
12/27/2001 | CA2413548A1 Root-specific promoter from arabidopsis |
12/27/2001 | CA2413502A1 Tumour-cell specific gene expression and its use in cancer therapy |
12/27/2001 | CA2413468A1 Methods and means for regulation of gene expression |
12/27/2001 | CA2413454A1 A g-protein coupled receptor |
12/27/2001 | CA2413452A1 Clk-2, cex-7 and coq-4 genes, and uses thereof |
12/27/2001 | CA2413451A1 Methods of identifying gabab receptor subtype-specific agonists |
12/27/2001 | CA2413450A1 Streptococcus antigens |
12/27/2001 | CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists |
12/27/2001 | CA2412942A1 Nucleic acid sequences and methods for the modification of plant gene expression |
12/27/2001 | CA2412840A1 The inactivation of nucleic acids using broad-spectrum pulsed light |
12/27/2001 | CA2412734A1 Renal regulatory elements and methods of use thereof |
12/27/2001 | CA2412502A1 Method for genome mining for secreted protein genes |
12/27/2001 | CA2412484A1 G-protein coupled receptors |
12/27/2001 | CA2412219A1 Transgenically produced platelet derived growth factor |
12/27/2001 | CA2412110A1 Osteolevin gene polymorphisms |
12/27/2001 | CA2412053A1 Grain processing method and transgenic plants useful therein |
12/27/2001 | CA2412013A1 Polynucleotides encoding human serine proteases |
12/27/2001 | CA2411978A1 Transgenic mice containing targeted gene disruptions |
12/27/2001 | CA2411971A1 Proteases |
12/27/2001 | CA2411896A1 Hypersensitive response eliciting domains of bacterial harpins and use thereof |
12/27/2001 | CA2411838A1 Protein expression profiling |
12/27/2001 | CA2411756A1 Mutation associated with epilepsy |
12/27/2001 | CA2411236A1 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii) |
12/27/2001 | CA2410864A1 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
12/27/2001 | CA2410857A1 Matrix screening method |
12/27/2001 | CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
12/27/2001 | CA2409781A1 Phosphodiesterases |
12/27/2001 | CA2409778A1 Secreted proteins |
12/27/2001 | CA2409776A1 G-protein coupled receptors |
12/27/2001 | CA2408630A1 Novel enterokinase cleavage sequences |
12/27/2001 | CA2407847A1 Transgenic animal model of neurodegenerative disorders |
12/27/2001 | CA2407788A1 Method for activating peroxisome proliferator activated receptor-.gamma. |
12/26/2001 | CN1328605A Methods for making recombinant cells |
12/26/2001 | CN1328604A Method for DNA or RNA sequencing |
12/26/2001 | CN1328602A Melanocortin-4 receptor gene and use as genetic marker for fat content, weight gain, and/or feed consumption animals |
12/26/2001 | CN1328571A Human monoclonal antibodies to CTLA-4 |
12/26/2001 | CN1328567A Mammaglobin, a secreted mammary-specific breast cancer protein |
12/26/2001 | CN1328415A Plant fatty acid desaturase promoters |
12/26/2001 | CN1328157A Efficient expression system of genetically engineered antibody eukaryon and its preparing process and application |
12/26/2001 | CN1328156A Process for preparing fusion protein used for glucose sensor |
12/26/2001 | CN1328155A Polypeptide-human topoisomeras I 9.79 and polynucleotide for coding it |
12/26/2001 | CN1328154A Polypeptide-DNA topoisomerase II-beta (TOP2B)10.34 and polynucleotide for coding it |
12/26/2001 | CN1328153A Polypeptide-dihydroorotase 10 and polynucleotide for coding it |
12/26/2001 | CN1328152A Polypeptide-human NRD transferase 10.01 and polynucleotide for coding it |
12/26/2001 | CN1328151A Polypeptide-proteasome p 40.5 subunit 9.79 and polynucleotide for coding it |
12/26/2001 | CN1328149A Polypeptide-phosphodiesterase 10.12 and polynucleotide for coding it |
12/26/2001 | CN1328148A Polypeptide-human protein phosphatase 9.68 and polynucleotide for coding it |
12/26/2001 | CN1328147A Polypeptide-human phosphatidase 49.06 and polynucleotide for coding it |
12/26/2001 | CN1328146A Polypeptide-phosphenolpyruvate-dependent sugar phosphotransferase 12 and polynucleotide for coding it |
12/26/2001 | CN1328145A Human mannose transferase and its coding sequence |
12/26/2001 | CN1328144A Polypeptide-methylated-DNA-protein-casteine methyltransferase 10 and polynucleotide for coding it |
12/26/2001 | CN1328142A Polypeptide-dihydropyrrole-5-carboxylate reductase 15 and polynucleotide for coding it |
12/26/2001 | CN1328141A Polypeptide-isopenicillin N synthase 31 and polynucleotide for coding it |
12/26/2001 | CN1328140A Polypeptide-citrate synthase 11.77 and polynucleotide for coding it |
12/26/2001 | CN1328139A Polypeptide-human 6-acetonylacyl tetrahydogen (biologic) pterin synthase (PTPS) 41.03 and polynucleotide for coding it |
12/26/2001 | CN1328138A Polypeptide-human RNA cyclase 12 and plynucleotide for coding it |
12/26/2001 | CN1328137A Polypeptide-human ubiquitin desmoenzyme 9.46 and polynucleotide for coding it |
12/26/2001 | CN1328136A Polypeptide-DNA topoisomerase II-beta (TOP2B) 29.48 and polynucleotide for coding it |
12/26/2001 | CN1328134A Coding sequence of protein kinase, polypeptide coded by it and its preparing process and usage |
12/26/2001 | CN1328132A Choline monooxidase gene and method for culturing drought-and salinity-resistant plant |
12/26/2001 | CN1328131A Cell strain of high-transfer bladder cancer and its creating process |
12/26/2001 | CN1328073A Application of pore fungus laccase |